Loading...
Quality Registry 2018-03-08T15:14:45+00:00

IT’S NOT JUST ABOUT BIG DATA –
IT’S ABOUT QUALITY DATA THAT MAKES A BIG DIFFERENCE.

That’s why we created the N1 Registry™. We collect the data that is most valuable to advance precision medicine and improve the quality of care for cancer patients.

“As the N1 Registry grows, we expect it will include many thousands of cases where the genomic data, patient phenotypic data, and clinical outcomes data are all aligned and high-quality, including rare cancers, which are essential to drawing significant conclusions that can inform precision cancer treatments. The need for this kind of comprehensive data is great and long overdue.”

JON HEUSEL, MD, PhD
Chief Medical Officer, Washington University Genomics and Pathology Services

THE N1 QUALITY REGISTRY

A registry is a collection of patients’ genetic data that is used to advance patient care. The revolutionary CureOne™ Quality Improvement Registry matches molecular testing to clinical outcomes. The N1 Registry adheres to stringent standards for data elements, collection, storage, auditing and reporting. It will help researchers, providers, laboratories, payers and pharmaceutical companies have access to a knowledge base that fills a major void in cancer research.

GET STARTED

What does being a Quality Improvement Registry (QIR) mean?

The N1 Registry™ is a Quality Improvement Registry because it takes the genomic data from multiple laboratories and clinical data from providers to identify the best testing and treatment options for patients. As a QIR, the N1 Registry will provide education in precision medicine to the cancer community. We will use advanced learning tools to accelerate the science needed to find a cure for cancer.